2m 2m 2m 2m 2m 2m 2m
KEROS THERAP (KROS)
NASDAQ
$11.36+$0.010 (+0.09%)
Price as of Oct 22, 2026 7:30 PM EDT- $221.7MMarket Cap
- -28.15%1-Year Change
- BiotechnologyIndustry
KEROS THERAP (KROS)
$11.36+$0.010 (+0.09%)
KROS | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $11.35 | ||
Change | -$0.22 (-1.93%) | ||
Open | $11.15 | ||
High | $11.44 | ||
Low | $11.15 | ||
Previous Close | $11.18 | ||
Volume | 115,512 | ||
30-Day Average Volume | 177,732 | ||
1-Week Change | 1.18% | ||
1-Month Change | -2.61% | ||
1-Year Change | -28.15% | ||
3-Year Change | -60.55% | ||
5-Year Change | -70.77% | ||
Fundamentals | |||
Shares Outstanding | 19.8M | ||
Total Assets | $287.6M | ||
Market Cap | $221.7M | ||
Enterprise Value | -$35.9M | ||
Period: QTR TTM FY | |||
Revenue | $0.00 | ||
Net Income | -$28.7M | ||
Free Cash Flow | -$20.6M | ||
EBIT | -$28.7M | ||
EBITDA | -$28.3M | ||
Net Working Capital | $254.7M | ||
EPS | -$1.45 | ||
Enterprise Value/EBITDA | 1 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 1 | ||
P/E | -8 | ||
PEG | 0 | ||
Price/Free Cash Flow | -11 | ||
Price/Operating Cash Flow | -11 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue